Nerve Growth Factor Signaling and Its Contribution to Pain

References

• Levi-Montalcini R, Angeletti PU. Essential role of the nerve growth factor in the survival and maintenance of dissociated sensory and sympathetic embryonic nerve cells in vitro. Dev Biol. 1963;6:653–659. doi:10.1016/0012-1606(63)90149-0
   PubMed Web of Science ®Google Scholar
• Gallo G, Lefcort FB, Letourneau PC. The trkA receptor mediates growth cone turning toward a localized source of nerve growth factor. J Neurosci. 1997;17(14):5445–5454. doi:10.1523/JNEUROSCI.17-14-05445.1997
   Web of Science ®Google Scholar
• Lindsay RM, Harmar AJ. Nerve growth factor regulates expression of neuropeptide genes in adult sensory neurons. Nature. 1989;337(6205):362–364. doi:10.1038/337362a0
   PubMed Web of Science ®Google Scholar
• Berry A, Bindocci E, Alleva E. NGF, brain and behavioral plasticity. Neural Plast. 2012;2012:784040. doi:10.1155/2012/784040
   PubMed Web of Science ®Google Scholar
• Chang DS, Hsu E, Hottinger DG, Cohen SP. Anti-nerve growth factor in pain management: current evidence. J Pain Res. 2016;9:373–383. doi:10.2147/JPR.S89061
   PubMed Web of Science ®Google Scholar
• Mantyh PW, Koltzenburg M, Mendell LM, Tive L, Shelton DL. Antagonism of nerve growth factor-TrkA signaling and the relief of pain. Anesthesiology. 2011;115(1):189–204. doi:10.1097/ALN.0b013e31821b1ac5
   PubMed Web of Science ®Google Scholar
• Allen SJ, Dawbarn D. Clinical relevance of the neurotrophins and their receptors. Clin Sci (Lond). 2006;110(2):175–191. doi:10.1042/CS20050161
   PubMed Web of Science ®Google Scholar
• Clewes O, Fahey MS, Tyler SJ, et al. Human ProNGF: biological effects and binding profiles at TrkA, P75NTR and sortilin. J Neurochem. 2008;107(4):1124–1135. doi:10.1111/j.1471-4159.2008.05698.x
   Web of Science ®Google Scholar
• Lee R, Kermani P, Teng KK, Hempstead BL. Regulation of cell survival by secreted proneurotrophins. Science. 2001;294(5548):1945–1948. doi:10.1126/science.1065057
   PubMed Web of Science ®Google Scholar
• Seidah NG, Benjannet S, Pareek S, et al. Cellular processing of the nerve growth factor precursor by the mammalian pro-protein convertases. Biochem J. 1996;314(Pt 3):951–960. doi:10.1042/bj3140951
   PubMed Web of Science ®Google Scholar
• Lim KC, Tyler CM, Lim ST, Giuliano R, Federoff HJ. Proteolytic processing of proNGF is necessary for mature NGF regulated secretion from neurons. Biochem Biophys Res Commun. 2007;361(3):599–604. doi:10.1016/j.bbrc.2007.07.039
   Web of Science ®Google Scholar
• Roux PP, Barker PA. Neurotrophin signaling through the p75 neurotrophin receptor. Prog Neurobiol. 2002;67(3):203–233. doi:10.1016/S0301-0082(02)00016-3
   PubMed Web of Science ®Google Scholar
• Ioannou MS, Fahnestock M. ProNGF, but not NGF, switches from neurotrophic to apoptotic activity in response to reductions in TrkA receptor levels. Int J Mol Sci. 2017;18(3). doi:10.1016/0306-4522(92)90237-V
   Web of Science ®Google Scholar
• Nykjaer A, Lee R, Teng KK, et al. Sortilin is essential for proNGF-induced neuronal cell death. Nature. 2004;427(6977):843–848. doi:10.1038/nature02319
   PubMed Web of Science ®Google Scholar
• Hempstead BL, Martin-Zanca D, Kaplan DR, Parada LF, Chao MV. High-affinity NGF binding requires coexpression of the trk proto-oncogene and the low-affinity NGF receptor. Nature. 1991;350(6320):678–683. doi:10.1038/350678a0
   PubMed Web of Science ®Google Scholar
• Jing S, Tapley P, Barbacid M. Nerve growth factor mediates signal transduction through trk homodimer receptors. Neuron. 1992;9(6):1067–1079. doi:10.1016/0896-6273(92)90066-M
   Web of Science ®Google Scholar
• Barker PA, Shooter EM. Disruption of NGF binding to the low affinity neurotrophin receptor p75LNTR reduces NGF binding to TrkA on PC12 cells. Neuron. 1994;13(1):203–215. doi:10.1016/0896-6273(94)90470-7
   PubMed Web of Science ®Google Scholar
• Berg MM, Sternberg DW, Hempstead BL, Chao MV. The low-affinity p75 nerve growth factor (NGF) receptor mediates NGF-induced tyrosine phosphorylation. Proc Natl Acad Sci U S A. 1991;88(16):7106–7110. doi:10.1073/pnas.88.16.7106
   Web of Science ®Google Scholar
• Hantzopoulos PA, Suri C, Glass DJ, Goldfarb MP, Yancopoulos GD. The low affinity NGF receptor, p75, can collaborate with each of the Trks to potentiate functional responses to the neurotrophins. Neuron. 1994;13(1):187–201. doi:10.1016/0896-6273(94)90469-3
   Web of Science ®Google Scholar
• Sharma N, Deppmann CD, Harrington AW, et al. Long-distance control of synapse assembly by target-derived NGF. Neuron. 2010;67(3):422–434. doi:10.1016/j.neuron.2010.07.018
   PubMed Web of Science ®Google Scholar
• Ceni C, Kommaddi RP, Thomas R, et al. The p75NTR intracellular domain generated by neurotrophin-induced receptor cleavage potentiates Trk signaling. J Cell Sci. 2010;123(Pt 13):2299–2307. doi:10.1242/jcs.062612
   Web of Science ®Google Scholar
• Bilderback TR, Gazula V-R, Dobrowsky RT. Phosphoinositide 3-kinase regulates crosstalk between Trk A tyrosine kinase and p75NTR-dependent sphingolipid signaling pathways. J Neurochem. 2001;76(5):1540–1551. doi:10.1046/j.1471-4159.2001.00171.x
   Web of Science ®Google Scholar
• Averill S, McMahon SB, Clary DO, Reichardt LF, Priestley JV. Immunocytochemical localization of trkA receptors in chemically identified subgroups of adult rat sensory neurons. Eur J Neurosci. 1995;7(7):1484–1494.
   Web of Science ®Google Scholar
• Wehrman T, He X, Raab B, Dukipatti A, Blau H, Garcia KC. Structural and mechanistic insights into nerve growth factor interactions with the TrkA and p75 receptors. Neuron. 2007;53(1):25–38. doi:10.1016/j.neuron.2006.09.034
   PubMed Web of Science ®Google Scholar
• Kaplan DR, Martin-Zanca D, Parada LF. Tyrosine phosphorylation and tyrosine kinase activity of the trk proto-oncogene product induced by NGF. Nature. 1991;350(6314):158–160. doi:10.1038/350158a0
   PubMed Web of Science ®Google Scholar
• Marlin MC, Li G. Biogenesis and function of the NGF/TrkA signaling endosome. Int Rev Cell Mol Biol. 2015;314:239–257.
   PubMed Web of Science ®Google Scholar
• Ehlers MD, Kaplan DR, Price DL, Koliatsos VE. NGF-stimulated retrograde transport of trkA in the mammalian nervous system. J Cell Biol. 1995;130(1):149–156. doi:10.1083/jcb.130.1.149
   Web of Science ®Google Scholar
• Davies AM. The neurotrophic hypothesis: where does it stand? Philos Trans R Soc Lond B Biol Sci. 1996;351(1338):389–394.
   PubMed Web of Science ®Google Scholar
• Fitzgerald M. Developmental biology of inflammatory pain. Br J Anaesth. 1995;75(2):177–185. doi:10.1093/bja/75.2.177
   Web of Science ®Google Scholar
• Crowley C, Spencer SD, Nishimura MC, et al. Mice lacking nerve growth factor display perinatal loss of sensory and sympathetic neurons yet develop basal forebrain cholinergic neurons. Cell. 1994;76(6):1001–1011. doi:10.1016/0092-8674(94)90378-6
   PubMed Web of Science ®Google Scholar
• Smeyne RJ, Klein R, Schnapp A, et al. Severe sensory and sympathetic neuropathies in mice carrying a disrupted Trk/NGF receptor gene. Nature. 1994;368(6468):246–249. doi:10.1038/368246a0
   PubMed Web of Science ®Google Scholar
• Einarsdottir E, Carlsson A, Minde J, et al. A mutation in the nerve growth factor beta gene (NGFB) causes loss of pain perception. Hum Mol Genet. 2004;13(8):799–805. doi:10.1093/hmg/ddh096
   PubMed Web of Science ®Google Scholar
• Carvalho OP, Thornton GK, Hertecant J, et al. A novel NGF mutation clarifies the molecular mechanism and extends the phenotypic spectrum of the HSAN5 neuropathy. J Med Genet. 2011;48(2):131–135. doi:10.1136/jmg.2010.081455
   Web of Science ®Google Scholar
• Larsson E, Kuma R, Norberg A, Minde J, Holmberg M. Nerve growth factor R221W responsible for insensitivity to pain is defectively processed and accumulates as proNGF. Neurobiol Dis. 2009;33(2):221–228. doi:10.1016/j.nbd.2008.10.012
   Web of Science ®Google Scholar
• Capsoni S, Covaceuszach S, Marinelli S, et al. Taking pain out of NGF: a “painless” NGF mutant, linked to hereditary sensory autonomic neuropathy type V, with full neurotrophic activity. PLoS One. 2011;6(2):e17321. doi:10.1371/journal.pone.0017321
   PubMed Web of Science ®Google Scholar
• Indo Y, Tsuruta M, Hayashida Y, et al. Mutations in the TRKA/NGF receptor gene in patients with congenital insensitivity to pain with anhidrosis. Nat Genet. 1996;13(4):485–488. doi:10.1038/ng0896-485
   PubMed Web of Science ®Google Scholar
• Indo Y. Molecular basis of congenital insensitivity to pain with anhidrosis (CIPA): mutations and polymorphisms in TRKA (NTRK1) gene encoding the receptor tyrosine kinase for nerve growth factor. Hum Mutat. 2001;18(6):462–471. doi:10.1002/humu.1224
   Web of Science ®Google Scholar
• Lewin GR, Ritter AM, Mendell LM. Nerve growth factor-induced hyperalgesia in the neonatal and adult rat. J Neurosci. 1993;13(5):2136–2148. doi:10.1523/JNEUROSCI.13-05-02136.1993
   PubMed Web of Science ®Google Scholar
• Zhu W, Galoyan SM, Petruska JC, Oxford GS, Mendell LM. A developmental switch in acute sensitization of small dorsal root ganglion (DRG) neurons to capsaicin or noxious heating by NGF. J Neurophysiol. 2004;92(5):3148–3152. doi:10.1152/jn.00356.2004
   Web of Science ®Google Scholar
• Kemp SWP, Webb AA, Dhaliwal S, Syed S, Walsh SK, Midha R. Dose and duration of nerve growth factor (NGF) administration determine the extent of behavioral recovery following peripheral nerve injury in the rat. Exp Neurol. 2011;229(2):460–470. doi:10.1016/j.expneurol.2011.03.017
   PubMed Web of Science ®Google Scholar
• Hui L, Yuan J, Ren Z, Jiang X. Nerve growth factor reduces apoptotic cell death in rat facial motor neurons after facial nerve injury. Neurosciences (Riyadh). 2015;20(1):65–68.
   Web of Science ®Google Scholar
• Orike N, Thrasivoulou C, Wrigley A, Cowen T. Differential regulation of survival and growth in adult sympathetic neurons: an in vitro study of neurotrophin responsiveness. J Neurobiol. 2001;47(4):295–305. doi:10.1002/neu.1036
   Web of Science ®Google Scholar
• Jones MG, Munson JB, Thompson SWN. A role for nerve growth factor in sympathetic sprouting in rat dorsal root ganglia. Pain. 1999;79(1):21–29. doi:10.1016/S0304-3959(98)00142-0
   Web of Science ®Google Scholar
• Heumann R, Lindholm D, Bandtlow C, et al. Differential regulation of mRNA encoding nerve growth factor and its receptor in rat sciatic nerve during development, degeneration, and regeneration: role of macrophages. Proc Natl Acad Sci U S A. 1987;84(23):8735–8739. doi:10.1073/pnas.84.23.8735
   Web of Science ®Google Scholar
• Calamandrei G, Alleva E, Cirulli F, et al. Serum NGF levels in children and adolescents with either Williams syndrome or Down syndrome. Dev Med Child Neurol. 2000;42(11):746–750. doi:10.1017/S0012162200001389
   Web of Science ®Google Scholar
• Woolf CJ, Safieh-Garabedian B, Ma QP, Crilly P, Winter J. Nerve growth factor contributes to the generation of inflammatory sensory hypersensitivity. Neuroscience. 1994;62(2):327–331. doi:10.1016/0306-4522(94)90366-2
   PubMed Web of Science ®Google Scholar
• Donnerer J, Schuligoi R, Stein C. Increased content and transport of substance P and calcitonin gene-related peptide in sensory nerves innervating inflamed tissue: evidence for a regulatory function of nerve growth factor in vivo. Neuroscience. 1992;49(3):693–698.
   Web of Science ®Google Scholar
• Grills BL, Schuijers JA. Immunohistochemical localization of nerve growth factor in fractured and unfractured rat bone. Acta Orthop Scand. 1998;69(4):415–419. doi:10.3109/17453679808999059
   PubMed Web of Science ®Google Scholar
• Longo G, Osikowicz M, Ribeiro-da-Silva A. Sympathetic fiber sprouting in inflamed joints and adjacent skin contributes to pain-related behavior in arthritis. J Neurosci. 2013;33(24):10066–10074. doi:10.1523/JNEUROSCI.5784-12.2013
   Web of Science ®Google Scholar
• Shelton DL, Zeller J, Ho WH, Pons J, Rosenthal A. Nerve growth factor mediates hyperalgesia and cachexia in auto-immune arthritis. Pain. 2005;116(1–2):8–16. doi:10.1016/j.pain.2005.03.039
   Web of Science ®Google Scholar
• Jimenez-Andrade JM, Martin CD, Koewler NJ, et al. Nerve growth factor sequestering therapy attenuates non-malignant skeletal pain following fracture. Pain. 2007;133(1–3):183–196. doi:10.1016/j.pain.2007.06.016
   PubMed Web of Science ®Google Scholar
• Ro LS, Chen ST, Tang LM, Jacobs JM. Effect of NGF and anti-NGF on neuropathic pain in rats following chronic constriction injury of the sciatic nerve. Pain. 1999;79(2–3):265–274. doi:10.1016/S0304-3959(98)00164-X
   PubMed Web of Science ®Google Scholar
• Bloom AP, Jimenez-Andrade JM, Taylor RN, et al. Breast cancer-induced bone remodeling, skeletal pain, and sprouting of sensory nerve fibers. J Pain. 2011;12(6):698–711. doi:10.1016/j.jpain.2010.12.016
   Web of Science ®Google Scholar
• Ghilardi JR, Freeman KT, Jimenez-Andrade JM, et al. Neuroplasticity of sensory and sympathetic nerve fibers in a mouse model of a painful arthritic joint. Arthritis Rheum. 2012;64(7):2223–2232.
   PubMed Web of Science ®Google Scholar
• Jimenez-Andrade JM, Ghilardi JR, Castaneda-Corral G, Kuskowski MA, Mantyh PW. Preventive or late administration of anti-NGF therapy attenuates tumor-induced nerve sprouting, neuroma formation, and cancer pain. Pain. 2011;152(11):2564–2574. doi:10.1016/j.pain.2011.07.020
   Web of Science ®Google Scholar
• Ishikawa G, Koya Y, Tanaka H, Nagakura Y. Long-term analgesic effect of a single dose of anti-NGF antibody on pain during motion without notable suppression of joint edema and lesion in a rat model of osteoarthritis. Osteoarthritis Cartilage. 2015;23(6):925–932. doi:10.1016/j.joca.2015.02.002
   PubMed Web of Science ®Google Scholar
• Koewler NJ, Freeman KT, Buus RJ, et al. Effects of a monoclonal antibody raised against nerve growth factor on skeletal pain and bone healing after fracture of the C57BL/6J mouse femur. J Bone Miner Res. 2007;22(11):1732–1742. doi:10.1359/jbmr.070711
   Web of Science ®Google Scholar
• LaBranche TP, Bendele AM, Omura BC, et al. Nerve growth factor inhibition with tanezumab influences weight-bearing and subsequent cartilage damage in the rat medial meniscal tear model. Ann Rheum Dis. 2017;76(1):295–302. doi:10.1136/annrheumdis-2015-208913
   PubMed Web of Science ®Google Scholar
• Miyagi M, Ishikawa T, Kamoda H, et al. Efficacy of nerve growth factor antibody in a knee osteoarthritis pain model in mice. BMC Musculoskelet Disord. 2017;18(1):428. doi:10.1186/s12891-017-1792-x
   Web of Science ®Google Scholar
• Sevcik MA, Ghilardi JR, Peters CM, et al. Anti-NGF therapy profoundly reduces bone cancer pain and the accompanying increase in markers of peripheral and central sensitization. Pain. 2005;115(1–2):128–141. doi:10.1016/j.pain.2005.02.022
   Web of Science ®Google Scholar
• Aloe L, Tuveri MA, Carcassi U, Levi-Montalcini R. Nerve growth factor in the synovial fluid of patients with chronic arthritis. Arthritis Rheum. 1992;35(3):351–355. doi:10.1002/art.1780350315
   PubMed Web of Science ®Google Scholar
• Halliday DA, Zettler C, Rush RA, Scicchitano R, McNeil JD. Elevated nerve growth factor levels in the synovial fluid of patients with inflammatory joint disease. Neurochem Res. 1998;23(6):919–922. doi:10.1023/A:1022475432077
   Web of Science ®Google Scholar
• Walsh DA, McWilliams DF, Turley MJ, et al. Angiogenesis and nerve growth factor at the osteochondral junction in rheumatoid arthritis and osteoarthritis. Rheumatology (Oxford). 2010;49(10):1852–1861. doi:10.1093/rheumatology/keq188
   PubMed Web of Science ®Google Scholar
• Iannone F, De Bari C, Dell’Accio F, et al. Increased expression of nerve growth factor (NGF) and high affinity NGF receptor (p140 TrkA) in human osteoarthritic chondrocytes. Rheumatology (Oxford). 2002;41(12):1413–1418. doi:10.1093/rheumatology/41.12.1413
   PubMed Web of Science ®Google Scholar
• Jiang YH, Peng CH, Liu HT, Kuo HC. Increased pro-inflammatory cytokines, C-reactive protein and nerve growth factor expressions in serum of patients with interstitial cystitis/bladder pain syndrome. PLoS One. 2013;8(10):e76779. doi:10.1371/journal.pone.0076779
   PubMed Web of Science ®Google Scholar
• Okragly AJ, Niles AL, Saban R, et al. Elevated tryptase, nerve growth factor, neurotrophin-3 and glial cell line-derived neurotrophic factor levels in the urine of interstitial cystitis and bladder cancer patients. J Urol. 1999;161(2):438–441; discussion 441–432. doi:10.1016/S0022-5347(01)61915-3
   Web of Science ®Google Scholar
• Liu HT, Tyagi P, Chancellor MB, Kuo HC. Urinary nerve growth factor level is increased in patients with interstitial cystitis/bladder pain syndrome and decreased in responders to treatment. BJU Int. 2009;104(10):1476–1481. doi:10.1111/j.1464-410X.2009.08675.x
   Web of Science ®Google Scholar
• Lowe EM, Anand P, Terenghi G, Williams-Chestnut RE, Sinicropi DV, Osborne JL. Increased nerve growth factor levels in the urinary bladder of women with idiopathic sensory urgency and interstitial cystitis. Br J Urol. 1997;79(4):572–577. doi:10.1046/j.1464-410X.1997.00097.x
   PubMedGoogle Scholar
• Watanabe T, Inoue M, Sasaki K, et al. Nerve growth factor level in the prostatic fluid of patients with chronic prostatitis/chronic pelvic pain syndrome is correlated with symptom severity and response to treatment. BJU Int. 2011;108(2):248–251. doi:10.1111/j.1464-410X.2010.09716.x
   PubMed Web of Science ®Google Scholar
• Giovengo SL, Russell IJ, Larson AA. Increased concentrations of nerve growth factor in cerebrospinal fluid of patients with fibromyalgia. J Rheumatol. 1999;26(7):1564–1569.
   PubMed Web of Science ®Google Scholar
• Sarchielli P, Alberti A, Floridi A, Gallai V. Levels of nerve growth factor in cerebrospinal fluid of chronic daily headache patients. Neurology. 2001;57(1):132–134. doi:10.1212/WNL.57.1.132
   PubMed Web of Science ®Google Scholar
• Sobue G, Yamamoto M, Doyu M, Li M, Yasuda T, Mitsuma T. Expression of mRNAs for neurotrophins (NGF, BDNF, and NT-3) and their receptors (p75NGFR, trk, trkB, and trkC) in human peripheral neuropathies. Neurochem Res. 1998;23(6):821–829. doi:10.1023/A:1022434209787
   Web of Science ®Google Scholar
• Freemont AJ, Watkins A, Le Maitre C, et al. Nerve growth factor expression and innervation of the painful intervertebral disc. J Pathol. 2002;197(3):286–292. doi:10.1002/path.1108
   PubMed Web of Science ®Google Scholar
• Richardson SM, Doyle P, Minogue BM, Gnanalingham K, Hoyland JA. Increased expression of matrix metalloproteinase-10, nerve growth factor and substance P in the painful degenerate intervertebral disc. Arthritis Res Ther. 2009;11(4):R126. doi:10.1186/ar2793
   PubMed Web of Science ®Google Scholar
• Aoki Y, Nakajima A, Ohtori S, et al. Increase of nerve growth factor levels in the human herniated intervertebral disc: can annular rupture trigger discogenic back pain? Arthritis Res Ther. 2014;16(4):R159. doi:10.1186/ar4674
   PubMed Web of Science ®Google Scholar
• Zhu Z, Friess H, diMola FF, et al. Nerve growth factor expression correlates with perineural invasion and pain in human pancreatic cancer. J Clin Oncol. 1999;17(8):2419–2428. doi:10.1200/JCO.1999.17.8.2419
   PubMed Web of Science ®Google Scholar
• Paterson S, Schmelz M, McGlone F, Turner G, Rukwied R. Facilitated neurotrophin release in sensitized human skin. Eur J Pain. 2009;13(4):399–405. doi:10.1016/j.ejpain.2008.05.005
   Web of Science ®Google Scholar
• Jablochkova A, Backryd E, Kosek E, et al. Unaltered low nerve growth factor and high brain-derived neurotrophic factor levels in plasma from patients with fibromyalgia after a 15-week progressive resistance exercise. J Rehabil Med. 2019;51(10):779–787. doi:10.2340/16501977-2593
   Web of Science ®Google Scholar
• Andreev N, Dimitrieva N, Koltzenburg M, McMahon SB. Peripheral administration of nerve growth factor in the adult rat produces a thermal hyperalgesia that requires the presence of sympathetic post-ganglionic neurones. Pain. 1995;63(1):109–115. doi:10.1016/0304-3959(95)00024-M
   PubMed Web of Science ®Google Scholar
• Davis BM, Lewin GR, Mendell LM, Jones ME, Albers KM. Altered expression of nerve growth factor in the skin of transgenic mice leads to changes in response to mechanical stimuli. Neuroscience. 1993;56(4):789–792. doi:10.1016/0306-4522(93)90127-2
   PubMed Web of Science ®Google Scholar
• Schnegelsberg B, Sun TT, Cain G, et al. Overexpression of NGF in mouse urothelium leads to neuronal hyperinnervation, pelvic sensitivity, and changes in urinary bladder function. Am J Physiol Regul Integr Comp Physiol. 2010;298(3):R534–R547. doi:10.1152/ajpregu.00367.2009
   PubMed Web of Science ®Google Scholar
• Petty BG, Cornblath DR, Adornato BT, et al. The effect of systemically administered recombinant human nerve growth factor in healthy human subjects. Ann Neurol. 1994;36(2):244–246. doi:10.1002/ana.410360221
   PubMed Web of Science ®Google Scholar
• Rukwied R, Mayer A, Kluschina O, Obreja O, Schley M, Schmelz M. NGF induces non-inflammatory localized and lasting mechanical and thermal hypersensitivity in human skin. Pain. 2010;148(3):407–413. doi:10.1016/j.pain.2009.11.022
   PubMed Web of Science ®Google Scholar
• Weinkauf B, Obreja O, Schmelz M, Rukwied R. Differential time course of NGF-induced hyperalgesia to heat versus mechanical and electrical stimulation in human skin. Eur J Pain. 2015;19(6):789–796. doi:10.1002/ejp.603
   Web of Science ®Google Scholar
• Andersen HH, Lo Vecchio S, Elberling J, Yosipovitch G, Arendt-Nielsen L. UVB- and NGF-induced cutaneous sensitization in humans selectively augments cowhage- and histamine-induced pain and evokes mechanical hyperknesis. Exp Dermatol. 2018;27(3):258–267. doi:10.1111/exd.13508
   PubMed Web of Science ®Google Scholar
• Andresen T, Nilsson M, Nielsen AK, Lassen D, Arendt-Nielsen L, Drewes AM. Intradermal injection with nerve growth factor: a reproducible model to induce experimental allodynia and hyperalgesia. Pain Pract. 2016;16(1):12–23. doi:10.1111/papr.12267
   PubMed Web of Science ®Google Scholar
• Weinkauf B, Obreja O, Schmelz M, Rukwied R. Differential effects of lidocaine on nerve growth factor (NGF)-evoked heat- and mechanical hyperalgesia in humans. Eur J Pain. 2012;16(4):543–549. doi:10.1016/j.ejpain.2011.08.004
   Web of Science ®Google Scholar
• Rukwied B, Weinkauf B, Main M, Obreja O, Schmelz M. Axonal hyperexcitability after combined NGF sensitization and UV-B inflammation in humans. Eur J Pain. 2014;18(6):785–793. doi:10.1002/j.1532-2149.2013.00423.x
   Web of Science ®Google Scholar
• Rukwied R, Weinkauf B, Main M, Obreja O, Schmelz M. Inflammation meets sensitization–an explanation for spontaneous nociceptor activity? Pain. 2013;154(12):2707–2714. doi:10.1016/j.pain.2013.07.054
   Web of Science ®Google Scholar
• Svensson P, Cairns BE, Wang K, Arendt-Nielsen L. Injection of nerve growth factor into human masseter muscle evokes long-lasting mechanical allodynia and hyperalgesia. Pain. 2003;104(1–2):241–247. doi:10.1016/S0304-3959(03)00012-5
   PubMed Web of Science ®Google Scholar
• Svensson P, Wang K, Arendt-Nielsen L, Cairns BE. Effects of NGF-induced muscle sensitization on proprioception and nociception. Exp Brain Res. 2008;189(1):1–10. doi:10.1007/s00221-008-1399-4
   Web of Science ®Google Scholar
• Svensson P, Castrillon E, Cairns BE. Nerve growth factor-evoked masseter muscle sensitization and perturbation of jaw motor function in healthy women. J Orofac Pain. 2008;22(4):340–348.
   PubMedGoogle Scholar
• Andersen H, Arendt-Nielsen L, Svensson P, Danneskiold-Samsoe B, Graven-Nielsen T. Spatial and temporal aspects of muscle hyperalgesia induced by nerve growth factor in humans. Exp Brain Res. 2008;191(3):371–382. doi:10.1007/s00221-008-1531-5
   Web of Science ®Google Scholar
• Gerber RK, Nie H, Arendt-Nielsen L, Curatolo M, Graven-Nielsen T. Local pain and spreading hyperalgesia induced by intramuscular injection of nerve growth factor are not reduced by local anesthesia of the muscle. Clin J Pain. 2011;27(3):240–247. doi:10.1097/AJP.0b013e3182048481
   Web of Science ®Google Scholar
• Lo Vecchio S, Petersen LJ, Finocchietti S, et al. Interaction between ultraviolet B-induced cutaneous hyperalgesia and nerve growth factor-induced muscle hyperalgesia. Eur J Pain. 2016;20(7):1058–1069. doi:10.1002/ejp.828
   Web of Science ®Google Scholar
• Vecchio SL, Finocchietti S, Gazerani P, Petersen LJ, Arendt-Nielsen L, Graven-Nielsen T. Heat-rekindling in UVB-irradiated skin above NGF-sensitized muscle: experimental models of prolonged mechanical hypersensitivity. Int J Physiol Pathophysiol Pharmacol. 2014;6(3):143–152.
   Google Scholar
• De Martino E, Zandalasini M, Schabrun S, Petrini L, Graven-Nielsen T. Experimental muscle hyperalgesia modulates sensorimotor cortical excitability, which is partially altered by unaccustomed exercise. Pain. 2018;159(12):2493–2502. doi:10.1097/j.pain.0000000000001351
   PubMed Web of Science ®Google Scholar
• Sorensen LB, Boudreau SA, Gazerani P, Graven-Nielsen T. Enlarged areas of pain and pressure hypersensitivity by spatially distributed intramuscular injections of low-dose nerve growth factor. J Pain. 2019;20(5):566–576. doi:10.1016/j.jpain.2018.11.005
   Web of Science ®Google Scholar
• Mista CA, Bergin MJG, Hirata RP, et al. Effects of prolonged and acute muscle pain on the force control strategy during isometric contractions. J Pain. 2016;17(10):1116–1125. doi:10.1016/j.jpain.2016.06.013
   Web of Science ®Google Scholar
• Nie H, Madeleine P, Arendt-Nielsen L, Graven-Nielsen T. Temporal summation of pressure pain during muscle hyperalgesia evoked by nerve growth factor and eccentric contractions. Eur J Pain. 2009;13(7):704–710. doi:10.1016/j.ejpain.2008.06.015
   Web of Science ®Google Scholar
• Munkholm TK, Arendt-Nielsen L. The interaction between NGF-induced hyperalgesia and acid-provoked pain in the infrapatellar fat pad and tibialis anterior muscle of healthy volunteers. Eur J Pain. 2017;21(3):474–485. doi:10.1002/ejp.941
   Web of Science ®Google Scholar
• Hayashi K, Shiozawa S, Ozaki N, Mizumura K, Graven-Nielsen T. Repeated intramuscular injections of nerve growth factor induced progressive muscle hyperalgesia, facilitated temporal summation, and expanded pain areas. Pain. 2013;154(11):2344–2352. doi:10.1016/j.pain.2013.07.007
   PubMed Web of Science ®Google Scholar
• Deising S, Weinkauf B, Blunk J, Obreja O, Schmelz M, Rukwied R. NGF-evoked sensitization of muscle fascia nociceptors in humans. Pain. 2012;153(8):1673–1679. doi:10.1016/j.pain.2012.04.033
   PubMed Web of Science ®Google Scholar
• Hirth M, Rukwied R, Gromann A, et al. Nerve growth factor induces sensitization of nociceptors without evidence for increased intraepidermal nerve fiber density. Pain. 2013;154(11):2500–2511. doi:10.1016/j.pain.2013.07.036
   Web of Science ®Google Scholar
• Obreja O, Ringkamp M, Turnquist B, et al. Nerve growth factor selectively decreases activity-dependent conduction slowing in mechano-insensitive C-nociceptors. Pain. 2011;152(9):2138–2146. doi:10.1016/j.pain.2011.05.021
   Web of Science ®Google Scholar
• Obreja O, Kluschina O, Mayer A, et al. NGF enhances electrically induced pain, but not axon reflex sweating. Pain. 2011;152(8):1856–1863. doi:10.1016/j.pain.2011.04.002
   Web of Science ®Google Scholar
• Obreja O, Rukwied R, Nagler L, Schmidt M, Schmelz M, Namer B. Nerve growth factor locally sensitizes nociceptors in human skin. Pain. 2018;159(3):416–426. doi:10.1097/j.pain.0000000000001108
   Web of Science ®Google Scholar
• Leon A, Buriani A, Dal Toso R, et al. Mast cells synthesize, store, and release nerve growth factor. Proc Natl Acad Sci U S A. 1994;91(9):3739–3743. doi:10.1073/pnas.91.9.3739
   PubMed Web of Science ®Google Scholar
• Nilsson G, Forsberg-Nilsson K, Xiang Z, Hallbook F, Nilsson K, Metcalfe DD. Human mast cells express functional TrkA and are a source of nerve growth factor. Eur J Immunol. 1997;27(9):2295–2301. doi:10.1002/eji.1830270925
   PubMed Web of Science ®Google Scholar
• Lambiase A, Bracci-Laudiero L, Bonini S, et al. Human CD4+ T cell clones produce and release nerve growth factor and express high-affinity nerve growth factor receptors. J Allergy Clin Immunol. 1997;100(3):408–414. doi:10.1016/S0091-6749(97)70256-2
   Web of Science ®Google Scholar
• Rost B, Hanf G, Ohnemus U, et al. Monocytes of allergics and non-allergics produce, store and release the neurotrophins NGF, BDNF and NT-3. Regul Pept. 2005;124(1–3):19–25. doi:10.1016/j.regpep.2004.06.024
   PubMedGoogle Scholar
• Dray A. Inflammatory mediators of pain. Br J Anaesth. 1995;75(2):125–131. doi:10.1093/bja/75.2.125
   Web of Science ®Google Scholar
• Rudick CN, Bryce PJ, Guichelaar LA, Berry RE, Klumpp DJ, Zimmer J. Mast cell-derived histamine mediates cystitis pain. PLoS One. 2008;3(5):e2096. doi:10.1371/journal.pone.0002096
   Web of Science ®Google Scholar
• Ren K, Torres R. Role of interleukin-1beta during pain and inflammation. Brain Res Rev. 2009;60(1):57–64. doi:10.1016/j.brainresrev.2008.12.020
   PubMed Web of Science ®Google Scholar
• Babenko V, Graven-Nielsen T, Svensson P, Drewes AM, Jensen TS, Arendt-Nielsen L. Experimental human muscle pain and muscular hyperalgesia induced by combinations of serotonin and bradykinin. Pain. 1999;82(1):1–8. doi:10.1016/S0304-3959(99)00026-3
   PubMed Web of Science ®Google Scholar
• Linhart O, Obreja O, Kress M. The inflammatory mediators serotonin, prostaglandin E2 and bradykinin evoke calcium influx in rat sensory neurons. Neuroscience. 2003;118(1):69–74. doi:10.1016/S0306-4522(02)00960-0
   Web of Science ®Google Scholar
• Sugiura T, Tominaga M, Katsuya H, Mizumura K. Bradykinin lowers the threshold temperature for heat activation of vanilloid receptor 1. J Neurophysiol. 2002;88(1):544–548. doi:10.1152/jn.2002.88.1.544
   Web of Science ®Google Scholar
• Khasar SG, Miao FJ-P, Janig W, Levine JD. Modulation of bradykinin-induced mechanical hyperalgesia in the rat by activity in abdominal vagal afferents. Eur J Neurosci. 1998;10(2):435–444. doi:10.1046/j.1460-9568.1998.00030.x
   Web of Science ®Google Scholar
• Bischoff SC, Dahinden CA. Effect of nerve growth factor on the release of inflammatory mediators by mature human basophils. Blood. 1992;79(10):2662–2669. doi:10.1182/blood.V79.10.2662.bloodjournal79102662
   Web of Science ®Google Scholar
• Tal M, Liberman R. Local injection of nerve growth factor (NGF) triggers degranulation of mast cells in rat paw. Neurosci Lett. 1997;221(2–3):129–132. doi:10.1016/S0304-3940(96)13318-8
   Web of Science ®Google Scholar
• Horigome K, Pryor JC, Bullock ED, Johnson EM Jr. Mediator release from mast cells by nerve growth factor. Neurotrophin specificity and receptor mediation. J Biol Chem. 1993;268(20):14881–14887.
   Web of Science ®Google Scholar
• Mazurek N, Weskamp G, Erne P, Otten U. Nerve growth factor induces mast cell degranulation without changing intracellular calcium levels. FEBS Lett. 1986;198(2):315–320. doi:10.1016/0014-5793(86)80428-8
   Web of Science ®Google Scholar
• Groneberg DA, Serowka F, Peckenschneider N, et al. Gene expression and regulation of nerve growth factor in atopic dermatitis mast cells and the human mast cell line-1. J Neuroimmunol. 2005;161(1–2):87–92. doi:10.1016/j.jneuroim.2004.12.019
   PubMed Web of Science ®Google Scholar
• Lopes DM, Denk F, Chisholm KI, et al. Peripheral inflammatory pain sensitisation is independent of mast cell activation in male mice. Pain. 2017;158(7):1314–1322. doi:10.1097/j.pain.0000000000000917
   Web of Science ®Google Scholar
• Susaki Y, Shimizu S, Katakura K, et al. Functional properties of murine macrophages promoted by nerve growth factor. Blood. 1996;88(12):4630–4637. doi:10.1182/blood.V88.12.4630.bloodjournal88124630
   Web of Science ®Google Scholar
• Shim W-S, Oh U. Histamine-induced itch and its relationship with pain. Mol Pain. 2008;4:29. doi:10.1186/1744-8069-4-29
   PubMed Web of Science ®Google Scholar
• Rosa AC, Fantozzi R. The role of histamine in neurogenic inflammation. Br J Pharmacol. 2013;170(1):38–45. doi:10.1111/bph.12266
   PubMed Web of Science ®Google Scholar
• Kasai M, Kumazawa T, Mizumura K. Nerve growth factor increases sensitivity to bradykinin, mediated through B2 receptors, in capsaicin-sensitive small neurons cultured from rat dorsal root ganglia. Neurosci Res. 1998;32(3):231–239. doi:10.1016/S0168-0102(98)00092-3
   Web of Science ®Google Scholar
• Lindholm D, Heumann R, Meyer M, Thoenen H. Interleukin-1 regulates synthesis of nerve growth factor in non-neuronal cells of rat sciatic nerve. Nature. 1987;330(6149):658–659. doi:10.1038/330658a0
   Web of Science ®Google Scholar
• Rueff A, Dawson AJ, Mendell LM. Characteristics of nerve growth factor induced hyperalgesia in adult rats: dependence on enhanced bradykinin-1 receptor activity but not neurokinin-1 receptor activation. Pain. 1996;66(2–3):359–372. doi:10.1016/0304-3959(96)03060-6
   Web of Science ®Google Scholar
• Bonnington JK, McNaughton PA. Signalling pathways involved in the sensitisation of mouse nociceptive neurones by nerve growth factor. J Physiol. 2003;551(Pt 2):433–446. doi:10.1113/jphysiol.2003.039990
   PubMed Web of Science ®Google Scholar
• Zhu W, Oxford GS. Phosphoinositide-3-kinase and mitogen activated protein kinase signaling pathways mediate acute NGF sensitization of TRPV1. Mol Cell Neurosci. 2007;34(4):689–700. doi:10.1016/j.mcn.2007.01.005
   Web of Science ®Google Scholar
• Chuang HH, Prescott ED, Kong H, et al. Bradykinin and nerve growth factor release the capsaicin receptor from PtdIns(4,5)P2-mediated inhibition. Nature. 2001;411(6840):957–962. doi:10.1038/35082088
   PubMed Web of Science ®Google Scholar
• Zhang X, Huang J, McNaughton PA. NGF rapidly increases membrane expression of TRPV1 heat-gated ion channels. EMBO J. 2005;24(24):4211–4223. doi:10.1038/sj.emboj.7600893
   PubMed Web of Science ®Google Scholar
• Bernstein CD, Diaz JH, Gould HJ 3rd. A possible role for zonisamide in treating neuropathic pain: a case of idiopathic polyneuropathy. Pain Pract. 2002;2(2):134–136. doi:10.1046/j.1533-2500.2002.02015.x
   Google Scholar
• Vulchanova L, Riedl MS, Shuster SJ, et al. P2X3 is expressed by DRG neurons that terminate in inner lamina II. Eur J Neurosci. 1998;10(11):3470–3478. doi:10.1046/j.1460-9568.1998.00355.x
   Web of Science ®Google Scholar
• D’Arco M, Giniatullin R, Simonetti M, et al. Neutralization of nerve growth factor induces plasticity of ATP-sensitive P2X3 receptors of nociceptive trigeminal ganglion neurons. J Neurosci. 2007;27(31):8190–8201. doi:10.1523/JNEUROSCI.0713-07.2007
   Web of Science ®Google Scholar
• Simonetti M, Fabbro A, D’Arco M, et al. Comparison of P2X and TRPV1 receptors in ganglia or primary culture of trigeminal neurons and their modulation by NGF or serotonin. Mol Pain. 2006;2:11. doi:10.1186/1744-8069-2-11
   PubMed Web of Science ®Google Scholar
• Giniatullin R, Nistri A, Fabbretti E. Molecular mechanisms of sensitization of pain-transducing P2X3 receptors by the migraine mediators CGRP and NGF. Mol Neurobiol. 2008;37(1):83–90. doi:10.1007/s12035-008-8020-5
   Web of Science ®Google Scholar
• Zhang YH, Vasko MR, Nicol GD. Ceramide, a putative second messenger for nerve growth factor, modulates the TTX-resistant Na(+) current and delayed rectifier K(+) current in rat sensory neurons. J Physiol. 2002;544(2):385–402. doi:10.1113/jphysiol.2002.024265
   Web of Science ®Google Scholar
• Stamboulian S, Choi JS, Ahn HS, et al. ERK1/2 mitogen-activated protein kinase phosphorylates sodium channel Na(v)1.7 and alters its gating properties. J Neurosci. 2010;30(5):1637–1647. doi:10.1523/JNEUROSCI.4872-09.2010
   Web of Science ®Google Scholar
• Hudmon A, Choi JS, Tyrrell L, et al. Phosphorylation of sodium channel Na(v)1.8 by p38 mitogen-activated protein kinase increases current density in dorsal root ganglion neurons. J Neurosci. 2008;28(12):3190–3201. doi:10.1523/JNEUROSCI.4403-07.2008
   Web of Science ®Google Scholar
• Malik-Hall M, Dina OA, Levine JD. Primary afferent nociceptor mechanisms mediating NGF-induced mechanical hyperalgesia. Eur J Neurosci. 2005;21(12):3387–3394. doi:10.1111/j.1460-9568.2005.04173.x
   Web of Science ®Google Scholar
• Zhuang ZY, Xu H, Clapham DE, Ji RR. Phosphatidylinositol 3-kinase activates ERK in primary sensory neurons and mediates inflammatory heat hyperalgesia through TRPV1 sensitization. J Neurosci. 2004;24(38):8300–8309. doi:10.1523/JNEUROSCI.2893-04.2004
   PubMed Web of Science ®Google Scholar
• Zhang YH, Nicol GD. NGF-mediated sensitization of the excitability of rat sensory neurons is prevented by a blocking antibody to the p75 neurotrophin receptor. Neurosci Lett. 2004;366(2):187–192. doi:10.1016/j.neulet.2004.05.042
   Web of Science ®Google Scholar
• Khodorova A, Nicol GD, Strichartz G. The p75NTR signaling cascade mediates mechanical hyperalgesia induced by nerve growth factor injected into the rat hind paw. Neuroscience. 2013;254:312–323. doi:10.1016/j.neuroscience.2013.09.046
   PubMed Web of Science ®Google Scholar
• Dobrowsky RT, Werner MH, Castellino AM, Chao MV, Hannun YA. Activation of the sphingomyelin cycle through the low-affinity neurotrophin receptor. Science. 1994;265(5178):1596–1599. doi:10.1126/science.8079174
   PubMed Web of Science ®Google Scholar
• Wong H, Kang I, Dong XD, et al. NGF-induced mechanical sensitization of the masseter muscle is mediated through peripheral NMDA receptors. Neuroscience. 2014;269:232–244. doi:10.1016/j.neuroscience.2014.03.054
   PubMed Web of Science ®Google Scholar
• Xue Q, Jong B, Chen T, Schumacher MA. Transcription of rat TRPV1 utilizes a dual promoter system that is positively regulated by nerve growth factor. J Neurochem. 2007;101(1):212–222. doi:10.1111/j.1471-4159.2006.04363.x
   Web of Science ®Google Scholar
• Stein AT, Ufret-Vincenty CA, Hua L, Santana LF, Gordon SE. Phosphoinositide 3-kinase binds to TRPV1 and mediates NGF-stimulated TRPV1 trafficking to the plasma membrane. J Gen Physiol. 2006;128(5):509–522. doi:10.1085/jgp.200609576
   PubMed Web of Science ®Google Scholar
• Camprubi-Robles M, Planells-Cases R, Ferrer-Montiel A. Differential contribution of SNARE-dependent exocytosis to inflammatory potentiation of TRPV1 in nociceptors. FASEB J. 2009;23(11):3722–3733. doi:10.1096/fj.09-134346
   PubMed Web of Science ®Google Scholar
• Gould HJ 3rd, Gould TN, England JD, Paul D, Liu ZP, Levinson SR. A possible role for nerve growth factor in the augmentation of sodium channels in models of chronic pain. Brain Res. 2000;854(1–2):19–29. doi:10.1016/S0006-8993(99)02216-7
   PubMed Web of Science ®Google Scholar
• Ramer MS, Bradbury EJ, McMahon SB. Nerve growth factor induces P2X(3) expression in sensory neurons. J Neurochem. 2001;77(3):864–875. doi:10.1046/j.1471-4159.2001.00288.x
   Web of Science ®Google Scholar
• Lee YJ, Zachrisson O, Tonge DA, McNaughton PA. Upregulation of bradykinin B2 receptor expression by neurotrophic factors and nerve injury in mouse sensory neurons. Mol Cell Neurosci. 2002;19(2):186–200. doi:10.1006/mcne.2001.1073
   Web of Science ®Google Scholar
• Petersen M, Segond von Banchet G, Heppelmann B, Koltzenburg M. Nerve growth factor regulates the expression of bradykinin binding sites on adult sensory neurons via the neurotrophin receptor p75. Neuroscience. 1998;83(1):161–168. doi:10.1016/S0306-4522(97)00374-6
   Web of Science ®Google Scholar
• Mamet J, Baron A, Lazdunski M, Voilley N. Proinflammatory mediators, stimulators of sensory neuron excitability via the expression of acid-sensing ion channels. J Neurosci. 2002;22(24):10662–10670. doi:10.1523/JNEUROSCI.22-24-10662.2002
   PubMed Web of Science ®Google Scholar
• Mamet J, Lazdunski M, Voilley N. How nerve growth factor drives physiological and inflammatory expressions of acid-sensing ion channel 3 in sensory neurons. J Biol Chem. 2003;278(49):48907–48913. doi:10.1074/jbc.M309468200
   Web of Science ®Google Scholar
• Matricon J, Muller E, Accarie A, et al. Peripheral contribution of NGF and ASIC1a to colonic hypersensitivity in a rat model of irritable bowel syndrome. Neurogastroenterol Motil. 2013;25(11):e740–e754. doi:10.1111/nmo.12199
   Web of Science ®Google Scholar
• Amann R, Schuligoi R, Herzeg G, Donnerer J. Intraplantar injection of nerve growth factor into the rat hind paw: local edema and effects on thermal nociceptive threshold. Pain. 1996;64(2):323–329. doi:10.1016/0304-3959(95)00120-4
   Web of Science ®Google Scholar
• Skoff AM, Adler JE. Nerve growth factor regulates substance P in adult sensory neurons through both TrkA and p75 receptors. Exp Neurol. 2006;197(2):430–436. doi:10.1016/j.expneurol.2005.10.006
   PubMed Web of Science ®Google Scholar
• Apfel SC. Nerve growth factor for the treatment of diabetic neuropathy: what went wrong, what went right, and what does the future hold? Int Rev Neurobiol. 2002;50:393–413.
   PubMed Web of Science ®Google Scholar
• Jimenez-Andrade JM, Mantyh PW. Sensory and sympathetic nerve fibers undergo sprouting and neuroma formation in the painful arthritic joint of geriatric mice. Arthritis Res Ther. 2012;14(3):R101. doi:10.1186/ar3826
   PubMed Web of Science ®Google Scholar
• Jimenez-Andrade JM, Bloom AP, Stake JI, et al. Pathological sprouting of adult nociceptors in chronic prostate cancer-induced bone pain. J Neurosci. 2010;30(44):14649–14656. doi:10.1523/JNEUROSCI.3300-10.2010
   PubMed Web of Science ®Google Scholar
• Cheng CF, Cheng JK, Chen CY, Rau RH, Chang YC, Tsaur ML. Nerve growth factor-induced synapse-like structures in contralateral sensory ganglia contribute to chronic mirror-image pain. Pain. 2015;156(11):2295–2309. doi:10.1097/j.pain.0000000000000280
   Web of Science ®Google Scholar
• Lin CL, Heron P, Hamann SR, Smith GM. Functional distinction between NGF-mediated plasticity and regeneration of nociceptive axons within the spinal cord. Neuroscience. 2014;272:76–87. doi:10.1016/j.neuroscience.2014.04.053
   PubMed Web of Science ®Google Scholar
• Romero MI, Rangappa N, Li L, Lightfoot E, Garry MG, Smith GM. Extensive sprouting of sensory afferents and hyperalgesia induced by conditional expression of nerve growth factor in the adult spinal cord. J Neurosci. 2000;20(12):4435–4445. doi:10.1523/JNEUROSCI.20-12-04435.2000
   PubMed Web of Science ®Google Scholar
• Gallo G, Letourneau PC. Localized sources of neurotrophins initiate axon collateral sprouting. J Neurosci. 1998;18(14):5403–5414. doi:10.1523/JNEUROSCI.18-14-05403.1998
   Web of Science ®Google Scholar
• Bjerre B, Bjorklund A, Mobley W, Rosengren E. Short- and long-term effects of nerve growth factor on the sympathetic nervous system in the adult mouse. Brain Res. 1975;94(2):263–277. doi:10.1016/0006-8993(75)90061-X
   Web of Science ®Google Scholar
• Mantyh WG, Jimenez-Andrade JM, Stake JI, et al. Blockade of nerve sprouting and neuroma formation markedly attenuates the development of late stage cancer pain. Neuroscience. 2010;171(2):588–598. doi:10.1016/j.neuroscience.2010.08.056
   PubMed Web of Science ®Google Scholar
• Deng YS, Zhong JH, Zhou XF. Effects of endogenous neurotrophins on sympathetic sprouting in the dorsal root ganglia and allodynia following spinal nerve injury. Exp Neurol. 2000;164(2):344–350. doi:10.1006/exnr.2000.7432
   Web of Science ®Google Scholar
• Campenot RB. Local control of neurite sprouting in cultured sympathetic neurons by nerve growth factor. Brain Res. 1987;465(1–2):293–301. doi:10.1016/0165-3806(87)90250-1
   Web of Science ®Google Scholar
• Goh EL, Chidambaram S, Ma D. Complex regional pain syndrome: a recent update. Burns Trauma. 2017;5:2. doi:10.1186/s41038-016-0066-4
   PubMed Web of Science ®Google Scholar
• Baron R, Schattschneider J, Binder A, Siebrecht D, Wasner G. Relation between sympathetic vasoconstrictor activity and pain and hyperalgesia in complex regional pain syndromes: a case-control study. Lancet. 2002;359(9318):1655–1660. doi:10.1016/S0140-6736(02)08589-6
   PubMed Web of Science ®Google Scholar
• Malcangio M, Garrett NE, Tomlinson DR. Nerve growth factor treatment increases stimulus-evoked release of sensory neuropeptides in the rat spinal cord. Eur J Neurosci. 1997;9(5):1101–1104. doi:10.1111/j.1460-9568.1997.tb01462.x
   Web of Science ®Google Scholar
• Bird GC, Han JS, Fu Y, Adwanikar H, Willis WD, Neugebauer V. Pain-related synaptic plasticity in spinal dorsal horn neurons: role of CGRP. Mol Pain. 2006;2:31. doi:10.1186/1744-8069-2-31
   PubMed Web of Science ®Google Scholar
• Murase K, Nedeljkov V, Randic M. The actions of neuropeptides on dorsal horn neurons in the rat spinal cord slice preparation: an intracellular study. Brain Res. 1982;234(1):170–176. doi:10.1016/0006-8993(82)90483-8
   Web of Science ®Google Scholar
• Randic M, Hecimovic H, Ryu PD. Substance P modulates glutamate-induced currents in acutely isolated rat spinal dorsal horn neurones. Neurosci Lett. 1990;117(1–2):74–80. doi:10.1016/0304-3940(90)90122-P
   Web of Science ®Google Scholar
• Nijs J, Meeus M, Versijpt J, et al. Brain-derived neurotrophic factor as a driving force behind neuroplasticity in neuropathic and central sensitization pain: a new therapeutic target? Expert Opin Ther Targets. 2015;19(4):565–576. doi:10.1517/14728222.2014.994506
   PubMed Web of Science ®Google Scholar
• Michael GJ, Averill S, Nitkunan A, et al. Nerve growth factor treatment increases brain-derived neurotrophic factor selectively in TrkA-expressing dorsal root ganglion cells and in their central terminations within the spinal cord. J Neurosci. 1997;17(21):8476–8490. doi:10.1523/JNEUROSCI.17-21-08476.1997
   PubMed Web of Science ®Google Scholar
• Zhou XF, Rush RA. Endogenous brain-derived neurotrophic factor is anterogradely transported in primary sensory neurons. Neuroscience. 1996;74(4):945–953. doi:10.1016/0306-4522(96)00237-0
   PubMed Web of Science ®Google Scholar
• Lever IJ, Bradbury EJ, Cunningham JR, et al. Brain-derived neurotrophic factor is released in the dorsal horn by distinctive patterns of afferent fiber stimulation. J Neurosci. 2001;21(12):4469–4477. doi:10.1523/JNEUROSCI.21-12-04469.2001
   PubMed Web of Science ®Google Scholar
• Zhang YH, Chi XX, Nicol GD. Brain-derived neurotrophic factor enhances the excitability of rat sensory neurons through activation of the p75 neurotrophin receptor and the sphingomyelin pathway. J Physiol. 2008;586(13):3113–3127. doi:10.1113/jphysiol.2008.152439
   Web of Science ®Google Scholar
• Garraway SM, Petruska JC, Mendell LM. BDNF sensitizes the response of lamina II neurons to high threshold primary afferent inputs. Eur J Neurosci. 2003;18(9):2467–2476. doi:10.1046/j.1460-9568.2003.02982.x
   Web of Science ®Google Scholar
• Woolf CJ. Windup and central sensitization are not equivalent. Pain. 1996;66(2–3):105–108. doi:10.1097/00006396-199608000-00001
   PubMed Web of Science ®Google Scholar
• Thompson SW, Dray A, McCarson KE, Krause JE, Urban L. Nerve growth factor induces mechanical allodynia associated with novel A fibre-evoked spinal reflex activity and enhanced neurokinin-1 receptor activation in the rat. Pain. 1995;62(2):219–231. doi:10.1016/0304-3959(94)00271-F
   Web of Science ®Google Scholar
• Balanescu AR, Feist E, Wolfram G, et al. Efficacy and safety of tanezumab added on to diclofenac sustained release in patients with knee or hip osteoarthritis: a double-blind, placebo-controlled, parallel-group, multicentre Phase III randomised clinical trial. Ann Rheum Dis. 2014;73(9):1665–1672. doi:10.1136/annrheumdis-2012-203164
   PubMed Web of Science ®Google Scholar
• Birbara C, Dabezies EJ Jr, Burr AM, et al. Safety and efficacy of subcutaneous tanezumab in patients with knee or hip osteoarthritis. J Pain Res. 2018;11:151–164. doi:10.2147/JPR.S135257
   Web of Science ®Google Scholar
• Brown MT, Murphy FT, Radin DM, Davignon I, Smith MD, West CR. Tanezumab reduces osteoarthritic knee pain: results of a randomized, double-blind, placebo-controlled phase III trial. J Pain. 2012;13(8):790–798. doi:10.1016/j.jpain.2012.05.006
   PubMed Web of Science ®Google Scholar
• Brown MT, Murphy FT, Radin DM, Davignon I, Smith MD, West CR. Tanezumab reduces osteoarthritic hip pain: results of a randomized, double-blind, placebo-controlled phase III trial. Arthritis Rheum. 2013;65(7):1795–1803. doi:10.1002/art.37950
   PubMed Web of Science ®Google Scholar
• Kivitz AJ, Gimbel JS, Bramson C, et al. Efficacy and safety of tanezumab versus naproxen in the treatment of chronic low back pain. Pain. 2013;154(7):1009–1021. doi:10.1016/j.pain.2013.03.006
   PubMed Web of Science ®Google Scholar
• Schnitzer TJ, Ekman EF, Spierings EL, et al. Efficacy and safety of tanezumab monotherapy or combined with non-steroidal anti-inflammatory drugs in the treatment of knee or hip osteoarthritis pain. Ann Rheum Dis. 2015;74(6):1202–1211. doi:10.1136/annrheumdis-2013-204905
   PubMed Web of Science ®Google Scholar
• Spierings EL, Fidelholtz J, Wolfram G, Smith MD, Brown MT, West CR. A phase III placebo- and oxycodone-controlled study of tanezumab in adults with osteoarthritis pain of the hip or knee. Pain. 2013;154(9):1603–1612. doi:10.1016/j.pain.2013.04.035
   PubMed Web of Science ®Google Scholar
• Nickel JC, Mills IW, Crook TJ, et al. Tanezumab reduces pain in women with interstitial cystitis/bladder pain syndrome and patients with nonurological associated somatic syndromes. J Urol. 2016;195(4 Pt 1):942–948. doi:10.1016/j.juro.2015.10.178
   Web of Science ®Google Scholar
• Tiseo PJ, Kivitz AJ, Ervin JE, Ren H, Mellis SJ. Fasinumab (REGN475), an antibody against nerve growth factor for the treatment of pain: results from a double-blind, placebo-controlled exploratory study in osteoarthritis of the knee. Pain. 2014;155(7):1245–1252. doi:10.1016/j.pain.2014.03.018
   PubMed Web of Science ®Google Scholar
• Tiseo PJ, Ren H, Mellis S. Fasinumab (REGN475), an antinerve growth factor monoclonal antibody, for the treatment of acute sciatic pain: results of a proof-of-concept study. J Pain Res. 2014;7:523–530. doi:10.2147/JPR.S65974
   PubMed Web of Science ®Google Scholar
• Schnitzer TJ, Easton R, Pang S, et al. Effect of tanezumab on joint pain, physical function, and patient global assessment of osteoarthritis among patients with osteoarthritis of the hip or knee: a randomized clinical trial. JAMA. 2019;322(1):37–48. doi:10.1001/jama.2019.8044
   PubMed Web of Science ®Google Scholar
• Krupka E, Jiang GL, Jan C. Efficacy and safety of intra-articular injection of tropomyosin receptor kinase A inhibitor in painful knee osteoarthritis: a randomized, double-blind and placebo-controlled study. Osteoarthritis Cartilage. 2019;27(11):1599–1607. doi:10.1016/j.joca.2019.05.028
   PubMed Web of Science ®Google Scholar
• Watt FE, Blauwet MB, Fakhoury A, Jacobs H, Smulders R, Lane NE. Tropomyosin-related kinase A (TrkA) inhibition for the treatment of painful knee osteoarthritis: results from a randomized controlled phase 2a trial. Osteoarthritis Cartilage. 2019;27(11):1590–1598. doi:10.1016/j.joca.2019.05.029
   PubMed Web of Science ®Google Scholar
• Miller RE, Block JA, Malfait AM. What is new in pain modification in osteoarthritis? Rheumatology (Oxford). 2018;57(suppl_4):iv99–iv107. doi:10.1093/rheumatology/kex522
   Web of Science ®Google Scholar
• Sheffield KS, Kennedy AE, Scott JA, Ross GM. Characterizing nerve growth factor-p75(NTR) interactions and small molecule inhibition using surface plasmon resonance spectroscopy. Anal Biochem. 2016;493:21–26. doi:10.1016/j.ab.2015.09.019
   Web of Science ®Google Scholar
• Sheffield KS, Vohra R, Scott JA, Ross GM. Using surface plasmon resonance spectroscopy to characterize the inhibition of NGF-p75(NTR) and proNGF-p75(NTR) interactions by small molecule inhibitors. Pharmacol Res. 2016;103:292–299. doi:10.1016/j.phrs.2015.12.005
   PubMed Web of Science ®Google Scholar
• Jiang H, Takeda K, Lazarovici P, et al. Nerve growth factor (NGF)-induced calcium influx and intracellular calcium mobilization in 3T3 cells expressing NGF receptors. J Biol Chem. 1999;274(37):26209–26216.
   PubMed Web of Science ®Google Scholar
• Jarvis CR, Xiong ZG, Plant JR, et al. Neurotrophin modulation of NMDA receptors in cultured murine and isolated rat neurons. J Neurophysiol. 1997;78(5):2363–2371. doi:10.1152/jn.1997.78.5.2363
   PubMed Web of Science ®Google Scholar
• Okuse K, Chaplan SR, McMahon SB, et al. Regulation of EXPRESSION of the Sensory Neuron-Specific Sodium Channel SNS in inflammatory and neuropathic pain. Mol Cell Neurosci. 1997;10(3):196–207. doi:10.1006/mcne.1997.0657
   Web of Science ®Google Scholar
• Lewis DL, De Aizpurua HJ, Rausch DM. Enhanced expression of Ca2+ channels by nerve growth factor and the v-src oncogene in rat phaeochromocytoma cells. J Physiol. 1993;465:325–342. doi:10.1113/jphysiol.1993.sp019679
   Web of Science ®Google Scholar
• Apfel SC, Wright DE, Wiideman AM, Dormia C, Snider WD, Kessler JA. Nerve growth factor regulates the expression of brain-derived neurotrophic factor mRNA in the peripheral nervous system. Mol Cell Neurosci. 1996;7(2):134–142. doi:10.1006/mcne.1996.0010
   PubMed Web of Science ®Google Scholar
• Schmelz M, Manthy P, Malfait AM, et al. Nerve growth factor antibody for the treatment of osteoarthritis pain and chronic low-back pain: mechanism of action in the context of efficacy and safety. Pain. 2019;160(10):2210–2220. doi:10.1097/j.pain.0000000000001625
   PubMed Web of Science ®Google Scholar